Company Filing History:
2 out of 258 
2 out of 323 
Years Active: 2012-2015
Title: **Vera Ignjatovic: Innovator in Peptide Substrates**
Introduction
Vera Ignjatovic, located in Armadale, Australia, is a notable inventor recognized for her contributions to the field of biochemistry, particularly in the development of peptide substrates. With a total of two patents to her name, she has made significant strides in the detection methodologies for enzymes, paving the way for advancements in medical diagnostics.
Latest Patents
Vera's latest patents include innovative reagents and methodologies for detecting free versus bound enzyme characteristics. One of her prominent inventions focuses on a modified peptide substrate designed to detect thrombin, regardless of its binding status to A2M. This invention proves useful in differentiating between thrombin that is unbound and that which is bound to A2M, by employing a sterically hindered substrate that prevents reaction with the bound thrombin. This groundbreaking work enhances the precision of biochemical assays and diagnostics.
Career Highlights
Throughout her career, Vera has had the opportunity to work with esteemed institutions such as McMaster University and The University of Melbourne. Her time at these institutions has not only enriched her experience but has also facilitated groundbreaking research in her field.
Collaborations
Vera Ignjatovic has collaborated with notable professionals, including Leslie Berry and Paul T Monagle. These collaborations have contributed to her innovative work, allowing for shared expertise and enhanced research outcomes that have significantly impacted the scientific community.
Conclusion
In conclusion, Vera Ignjatovic stands out as a prominent inventor with valuable contributions to enzyme detection methodologies. With her background and collaboration with respected institutions and professionals, her work continues to influence advancements in biochemical diagnostics. Her patents promise to play a pivotal role in enhancing the understanding and detection of thrombin, ultimately benefiting medical science and patient care.